Navigation Links
Nektar Therapeutics Announces Second Quarter 2008 Results
Date:8/6/2008

p>Loss from operations (33,358) (27,988) (75,247) (53,957)

Non-operating income (expense):

Interest income 3,190 5,452 8,203 10,925

Interest expense (3,929) (4,702) (7,847) (9,635)

Other expense, net 769 (22) 1,071 (16)

Total non-operating income 30 728 1,427 1,274

Loss before provision for income

taxes (33,328) (27,260) (73,820) (52,683)

Provision for income taxes 47 250 260 500

Net loss $(33,375) $(27,510) $(74,080) $(53,183)

Basic and diluted net loss per

share $(0.36) $(0.30) $(0.80) $(0.58)

Shares used in computing basic and

diluted net loss per share 92,400 91,804 92,365 91,630

NEKTAR THERAPEUTICS

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

June 30, December 31,

2008 2007

(unaudited) (1)

ASSETS

Current assets:

Cash and cash equivalents $31,829 $76,293

Short-term investments 342,078 406,060

Accounts receivable, net of

allowance 12,067 21,637

Inventory 10,166 12,187

Other current assets 13,988 7,106

Total current assets 410,128 523,283

Property and equipment, net 114,229 114,420
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
2. Nektar Therapeutics Announces First Quarter 2008 Results
3. FDA Approval of Cimzia(R) for Crohns Disease Represents Latest Milestone for Nektars PEGylation Technology Platform
4. Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
5. Nektar to Announce 2007 Year-End Financial Results on Wednesday, February 27, 2008, After Close of U.S.-Based Financial Markets
6. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
7. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
8. Nektars Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York
9. Nektar Therapeutics Announces Third Quarter 2007 Financial Results
10. Nektar to Announce Third Quarter 2007 Financial Results on Wednesday, November 7, 2007, After the Close of U.S. Financial Markets
11. InteKrin Therapeutics Announces $20 Million Series C Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... March 06, 2015 In a new study ... mesothelioma patients reported that shoulder pain was their first mesothelioma ... its website. Click here to read it now. ... the medical records of 49 mesothelioma patients between ... that it was shoulder pain that first prompted them to ...
(Date:3/6/2015)... FCPX developers have announced a new animated ... Hue is a lower 3rd pack with a clean and ... “Blurring the line between professional and armature, Pro3rd Hue is ... of 30 customizable lower third presets made exclusively for use ... can complement any design with a clean and simplistic style. ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Fluid Running® ... Marathon qualifier, developed the Fluid Running® method ... before the Chicago marathon. She hit upon the trifecta ... group run, and a maximum-resistance, deep water running technique. ... unique no-impact, deep water running workout that made the ...
(Date:3/5/2015)... From Oct. 5-10, Mumbai, India will serve as host to ... include the following activities:, October 5: ... 6: Conference Day 1, ending with a Fashion Show and ... with Local Entertainment and Dinner , October 8: ... , October 9-10: Textiles in India Tour (optional; ...
(Date:3/5/2015)... This week, 60 Minutes ... laminate flooring products, initiating widespread concern from homeowners. ... materials made primarily from bamboo, stands behind their ... flooring products for volatile organic compounds (VOCs) through ... (BMH). Results from formaldehyde emissions testing show ...
Breaking Medicine News(10 mins):Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2Health News:A New Plugin Entitled Pro3rd Hue was Released Today from Pixel Film Studios Exclusively for FCPX 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 3Health News:Textile Exchange Announces the 2015 Textile Sustainability Conference Dates 2Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2
... a Million People Nationwide to take 10 Billion, Steps ... WASHINGTON, Sept. 17 More than 1,500 YMCAs ... active living and,healthy eating during "America On the Move ... partnership with the America On the Move,Foundation, aims to ...
... Science Series to Focus on Cardiovascular Disease, Prevention and Treatment Options, ... ... NEW YORK, Sept. 17 The upcoming episode of the "Charlie,Rose ... leading,global killers, which claims almost 900,000 lives each year in the United,States ...
... A new study by researchers at the University of Southern ... , Researchers found that a storyline on the primetime ... and healthy eating habits had a positive impact on the ... study, published in the Sept. 14 Journal of Health Communication ...
... cancer in the head and neck region may have ... without the disease, according to a report in the ... one of the JAMA/Archives journals. , Driving is a ... functions that work together. These functions can be compromised ...
... the Medicare,Quality Improvement Organization for Florida, is ... Laredo, Texas to provide free Diabetes,Empowerment Education ... 33,Florida counties. According to Kathleen Lightbourne, Project ... "The Program is designed to help,people with ...
... Open House - Saturday, October 20,Event to be held ... WEST PLAINS, Mo., Sept. 17 GAMMILL QUILTING ... systems, in,cooperation with it,s nationwide network of dealers, will ... 20. This event is being,held in honor of October,s ...
Cached Medicine News:Health News:Activate America(R) Brings Together YMCAs Nationwide to Promote Small Steps Toward a Healthier Lifestyle During 'America on the Move Week With the YMCA,' September 22-29, 2007 2Health News:Activate America(R) Brings Together YMCAs Nationwide to Promote Small Steps Toward a Healthier Lifestyle During 'America on the Move Week With the YMCA,' September 22-29, 2007 3Health News:Activate America(R) Brings Together YMCAs Nationwide to Promote Small Steps Toward a Healthier Lifestyle During 'America on the Move Week With the YMCA,' September 22-29, 2007 4Health News:Activate America(R) Brings Together YMCAs Nationwide to Promote Small Steps Toward a Healthier Lifestyle During 'America on the Move Week With the YMCA,' September 22-29, 2007 5Health News:Charlie Rose Science Series Explores Heart Disease 2Health News:Charlie Rose Science Series Explores Heart Disease 3Health News:ER episode impacts viewers' health knowledge and behavior 2Health News:Patients with head and neck cancer may have impairment of some driving skills 2Health News:Medicare Every Diabetic Counts Project Gears Up for Kick-Off 2Health News:'Think Pink with Gammill(R)' 2
(Date:3/5/2015)... WASHINGTON , March 5, 2015 ... applauds the Food and Drug Administration,s (FDA) approval ... (nivolumab). Opdivo and other immunotherapy treatments add another ... by harnessing the power of a patient,s own ... drug has been approved specifically for patients with ...
(Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... the "India Pharma Outlook 2015: Accelerating growth to ... beyond Generics" report to their offering. ... slump in the 2013 caused by the market,s reaction ... is expected to continue to be healthy, as the ...
(Date:3/5/2015)... 05, 2015 Research and Markets ( ... "Japan Pharma Outlook 2015: Year to Watch out for ... report to their offering. The new ... from April -2014 (Annexure 1) is a game changer ... generic or innovator. The most of the companies are ...
Breaking Medicine Technology:LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3
... the ,It,s Your Passion. Let It Out, Contest, ... today,announced the 20th anniversary of the company,s Kogenate(R) ... hemophilia A research, collaboration,and community building at the ... Istanbul, Turkey. More than 8 billion international units,of ...
... added to hormone therapy, following surgery, significantly reduced the risk of cancer returning ... benefits achieved with hormone therapy alone(1) - Findings ... hormone-sensitive, early-stage breast ... cancer, - These are the ...
Cached Medicine Technology:Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress 2Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress 3Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 2Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 3Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 4Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 5Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 6Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 7Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 8Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 9
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: